Literature DB >> 8284510

Comparison of serum, milk and urine as samples in an enzyme immunoassay for bovine leukaemia virus infection.

K T Carli1, H Batmaz, A Sen, A Minbay.   

Abstract

Serum, milk and urine specimens were taken from 15 bovine leukaemia virus (BLV)-positive and 20 BLV-negative cattle which had been determined previously to be infected or not by the use of a monoclonal enzyme-linked immunosorbent assay (ELISA). An ELISA was performed on the samples for the detection of IgG1 antibodies to the BLV surface glycoprotein, gp 51. The three types of samples had parallel optical density (OD) values apart from three urine samples which, although accepted as negative for anti-BLV antibodies, had numerically higher ODS than those of control BLV-negative animals. Therefore, detection of IgG1 antibodies against BLV in the urine of naturally infected animals could be an indication for the use of urine for diagnosis of BLV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8284510     DOI: 10.1016/0034-5288(93)90117-x

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

1.  Enzyme-linked immunosorbent assay for the diagnosis of bovine leukosis: comparison with the agar gel immunodiffusion test approved by the Canadian Food Inspection Agency.

Authors:  C Simard; S Richardson; P Dixon; C Bélanger; P Maxwell
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

2.  Hepatitis E antibody profiles in serum and urine.

Authors:  M S Joshi; A M Walimbe; V A Arankalle; M S Chadha; S D Chitambar
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  Evaluation of urine as a clinical specimen for diagnosis of hepatitis a.

Authors:  Madhuri S Joshi; Shobha D Chitambar; Vidya A Arankalle; Mandeep S Chadha
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 4.  Urinary immunoglobulins in viral diagnosis: An overview.

Authors:  Sreelekshmy Mohandas; Sudeep Balan; Devendra T Mourya
Journal:  Indian J Med Res       Date:  2022-01       Impact factor: 5.274

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.